ABDİ İBRAHİM VAKFI
SUSTAINABILITY STRATEGY FUTURE OF THE ECOSYSTEM FUTURE OF THE PEOPLE FUTURE OF THE BUSINESS

SUSTAINABILITY
STRATEGY

Healing the Future

Abdi İbrahim harnesses the power of science and technology to seamlessly integrate sustainability into its business processes, aiming to mend the future of the ecosystem, people and work. This commitment is central to its sustainability strategy, focused on creating enduring value.

We aspire to see the transformation we have initiated through our international leadership vision and our commitment to "Healing the Future" support meaningful changes that shape and heal the world ahead. To this end, we center our sustainability journey on three primary domains, and strive to heal "the future of the ecosystem, the future of people and the future of work" Our sustainability strategy, designed with a long-term value creation perspective, is reinforced by the ambitious milestones we have set for 2030, 2040 and 2050. While diligently advancing our work in alignment with our strategic priorities, we anchor our operations in transparency, fairness, responsibility and accountability, fostering collaborations on our path towards achieving our goals.

Value Chain

1. Product development and R&D

  • Developing innovative products

  • Bioequivalence studies

  • Signature product development processes

  • Finding new treatment methods

  • Conducting clinical research aimed at improving or benchmarking existing treatment methods

  • Evaluating and reporting the risks and benefits of products

  • Exploring packaging alternatives with low environmental impact

192 million in R&D expenditure

2. Material supply

  • Raw material supply and inventory management

  • Managing the procurement of raw materials, materials and production equipment from suppliers

  • Exploring sustainable packaging alternatives

  • Supplier evaluation processes

2018 suppliers

3. Licensing

  • Preparing the licensing documents of medicinal products for human use containing chemical and biological active substances

  • Managing the licensing processes

  • Preparing the application documents and obtaining approvals for products in the cosmetic, medical device and food supplement categories

  • Supporting the procedures of launching the products

A total of 148 products were licensed for all countries in 2022.

4. Production of pharmaceuticals and consumer health products

  • Production facilities in 3 countries; Türkiye, Kazakhstan, Algeria

  • Production services for national and international companies

  • The Esenyurt Production Complex powered by 100% renewable electricity

5. Product packaging

  • Packaging material reduction efforts

  • Exploring packaging alternatives with low environmental impact

As part of the Green Harmonization project, greenhouse gas emissions resulting from packaging materials were reduced by 28 percent per product and 179 tonnes of packaging materials were saved.

6. Storage and distribution

  • Optimization of storage and distribution processes

  • At the Abdi İbrahim Technologistics Center, all operations, including material movements, are executed with computerized precision, without manual intervention. 1,200 pallets are moved on a daily basis.

In 2022;

Approximately 7,500 EUR-pallets of pharmaceuticals were exported to 53 countries.

More than 38,000 EUR-pallets were shipped to 26 companies as part of contract manufacturing.

Approximately 87,000 pallets were handled in the finished goods warehouse.

7. Marketing and sales

  • 228 brands and 458 products in Türkiye

  • 120 brands and 220 products in international markets

  • Exports to more than 70 countries

  • Collaboration with more than 30 licensors

  • Abdi İbrahim teams operating in 18 countries

  • 2760 people-strong marketing-sales team

8. Product end of life

  • Packaging reduction efforts

  • Exploring biodegradable packaging alternatives

This figure presents 2022 data.

Contributions to the Sustainable Development Goals

Guided by the Sustainable Development Goals (SDGs), which are the United Nations' universal call for action to eliminate poverty, protect our planet and ensure that all people live in peace and prosperity, Abdi İbrahim determined its sustainability actions in line with the materiality analysis carried out in 2020. Abdi İbrahim clusters these material issues to address nine SDGs simultaneously in consideration of the United Nations 2030 agenda and establishes its areas of activity accordingly. Using its skills, competencies and existing resources, Abdi İbrahim continues to contribute to these global goals, and provide lasting value in every step.

Supported SDG

Issues of very high importance

R&D and innovation

SDG 8
SDG 9
SDG 17

Biotechnological products

Localization

Stakeholder relations

SDG 9
SDG 12

Talent management

SDG 8

Issues of high importance

Climate change and energy management

SDG 12
SDG 13
SDG 17

Waste management

Drug safety and side effects

SDG 9

Intellectual property and patents

Business ethics and transparency

SDG 10

Business ethics and transparency

SDG 8
SDG 10
SDG 13
SDG 17

Occupational health and safety

SDG 8
SDG 12

Environmental

Social

Governance

Sustainability Goals

HEAL THE FUTURE

In our sustainability journey that we set out with our international leadership vision and the goal of “Healing the Future"; we heal "Our Ecosystem, Business and People".

Healing The Future
of Ecosystem

Healing The Future
of People

Healing The Future
of Business

We heal the future of the ecosystem by ensuring environmental sustainability across the entire value chain.

We focus on using natural resources efficiently and aim to minimise our resource consumption.

We heal the future of all our stakeholders, especially our employees.

Healing the future of business with our industry leadership and sense of responsibility.

2030 TARGETS

Becoming a Carbon Neutral company

Reduce Scope 1 and 2 greenhouse gas emissions by 60 per cent compared with 2020, the base year

Reduce Scope 3 greenhouse gas emissions by 45% compared with 2020, the base year

Increasing the amount of sustainable packaging by 5% for consumer health products

Measuring the impact of the investments made (SROI)

To increase the proportion of women in management (manager and above) to 45 per cent

Increasing the average training hours per employee to 30

Increasing the ratio of local suppliers to 80% in Turkey operations

Collection of sustainability data from critical suppliers*

*Creating 80 per cent of the direct purchasing volume

2040 TARGETS

Reduce Scope 1 and 2 greenhouse gas emissions by 75 per cent compared with 2020, the base year

Reduce all scope 3 greenhouse gas emissions by 60 per cent compared with 2020, the base year

Increase impact-orientated collaboration

Implementing programmes to improve the sustainability performance of critical suppliers

2050 TARGETS

Achieving Net Zero Emissions

To realise social investment projects that create a higher impact than the investment made

To increase the ratio of women in management to 50 per cent

Increase investments in the future of the business

-

Decarbonisation

We act with the vision of "Net Zero" emissions throughout our value chain.

Good for the Employees

We develop competences for the future of the sector, and we observe diversity, equality and inclusion.

Leadership

We are transforming our business in line with our vision of producing in the country starting from the cell, and we aim to carry our leadership in Turkey to the international level with our wide product portfolio and investments in biotechnology.

Product Sustainability

We adopt circular economy principles from the design stage.

Good for the People

We support scientific awareness and focus on the well-being of society through social innovation, volunteering activities and social investments.

Responsible Supply Chain

We act according to responsible purchasing principles at every stage of our supply chain.

Circularity

Recycling of pharmaceutical and consumer health product packaging at the final consumption stage

Ethics, Transparency and Compliance

We are based on transparent, fair, responsible and accountable operations.

Collaborations

We make impact-oriented collaborations on the way to our goals.

Innovation

REPORTS

Tercihleriniz Bizim İçin Önemli!

Site deneyiminizi iyileştirmek, içerikleri ve reklamları kişiselleştirmek ve site trafiğini analiz etmek amacıyla çerezler kullanıyoruz. Çerezler hakkında detaylı bilgi için Çerez Politikamızı inceleyebilirsiniz. Kesinlikle gerekli olmayan çerezlerin kullanımına ve çerezler aracılığıyla toplanan kişisel verilerinizin yurt dışına aktarılmasına onay vermek için “Tümünü Kabul Et” butonuna tıklayabilirsiniz.

Çerez Ayarları
Kapat